MedPath

Comparison of Diode laser compared to CO2 laser in the management of leukoplakia

Not Applicable
Suspended
Conditions
Health Condition 1: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue
Registration Number
CTRI/2023/01/048764
Lead Sponsor
All India institute of medical sciences Patna
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients diagnosed clinically and histopathologically with no dysplasia and mild of moderate dysplasia.

Oral Leukoplakia aged between 20 to 70 years, irrespective of the gender,

Patient with history of tobacco chewing and those who are willing to undergo laser therapy.

Patients with persistent lesion even after 1 month of counseling and tobacco cessation.

Patient ready to quit habit.

Patient ready for biopsy

Exclusion Criteria

Patients having severe dysplasia confirmed by histopathologically.

Patients with history of any systemic disease or disorders

Patients who fail to give written consent

Histopathological severe dysplastic changes.

Lesions regressed with antifungal agent will be excluded from the study.

Lesions with no history of tobacco/ Idiopathic leukoplakia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The objectives of the study is to compare the effectiveness (Pain, edema, infection, scar, healing pattern and recurrence rate) of Diode laser compared to CO2 laser for the treatment of leukoplakia.Timepoint: Details of duration and outcome measure are as follows- <br/ ><br>2nd day-Pain, Healing pattern. <br/ ><br>1 week-Pain, Healing pattern <br/ ><br>2 week-Pain, Healing pattern <br/ ><br>1 month-Healing pattern, Scarring <br/ ><br>3 months-Recurrences. <br/ ><br>6 months-Recurrences. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
not applicableTimepoint: 00
© Copyright 2025. All Rights Reserved by MedPath